Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in Acute Myocardial Infarction
NCT02931045Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial of ticagrelor in myocardial infarction (MI) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Concentration of Platelet Extracellular Vesicles/ml at 6 months. Started Dec 2017; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02931045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02931045.